Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease
Kamonpan Sanachai, Panupong Mahalapbutr, Vannajan Sanghiran Lee, et al.
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 50, pp. 13644-13656
Closed Access | Times Cited: 19

Showing 19 citing articles:

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO
Kowit Hengphasatporn, Ryuhei Harada, Patcharin Wilasluck, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Discovery of amphotericin B, an antifungal drug as tyrosinase inhibitor with potent anti-melanogenic activity
Panupong Mahalapbutr, Sahachai Sabuakham, Sutita Nasoontorn, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125587-125587
Closed Access | Times Cited: 10
Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via in silico studies
Ayşe Tan
Journal of Molecular Structure (2022) Vol. 1261, pp. 132915-132915
Open Access | Times Cited: 14
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1461-1461
Open Access | Times Cited: 12
Molecular Dynamics as a Tool for Virtual Ligand Screening
Grégory Menchon, Laurent Maveyraud, Georges Czaplicki
Methods in molecular biology (2023), pp. 33-83
Closed Access | Times Cited: 6
Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
Huarui Qiao, Lingyun Li, Lu Wang, et al.
Protein Expression and Purification (2023) Vol. 207, pp. 106267-106267
Open Access | Times Cited: 5
Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CLpro through Structure-Based Virtual Screening and Experimental Approaches
Piyatida Pojtanadithee, Kowit Hengphasatporn, Aphinya Suroengrit, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5244-5258
Closed Access | Times Cited: 5
Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds
Kamonpan Sanachai, Panupong Mahalapbutr, Lueacha Tabtimmai, et al.
ACS Omega (2022) Vol. 7, Iss. 37, pp. 33587-33598
Open Access | Times Cited: 9
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies
Quaiser Saquib, Ahmed H. Bakheit, Sarfaraz Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 998-998
Open Access | Times Cited: 1
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: in vitro and in silico studies
Sahachai Sabuakham, Sutita Nasoontorn, Napat Kongtaworn, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 1
Structural dynamics and susceptibility of isobutylamido thiazolyl resorcinol (Thiamidol TM ) against human and mushroom tyrosinases
Panupong Mahalapbutr, Napat Nuramrum, Thanyada Rungrotmongkol, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11810-11817
Closed Access | Times Cited: 3
Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
Aye Chan Khine Lin, Ponsawan Netcharoensirisuk, Kamonpan Sanachai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Molecular insights into natural product compounds targeting papain protease of SARS-CoV-2 through molecular dynamics simulation
Chananya Rajchakom, Nitchakan Darai, Thitiya Boonma, et al.
Monatshefte für Chemie - Chemical Monthly (2024)
Closed Access
Identification of Potential Anti‐COVID‐19 Drug Leads from Medicinal Plants through Virtual High‐Throughput Screening
Rohoullah Firouzi, Mitra Ashouri
ChemistrySelect (2023) Vol. 8, Iss. 7
Closed Access | Times Cited: 1
The Kinetic parameters, Thermodynamic parameters, and Mechanism of PLpro from SARS-CoV and SARS-CoV-2
Da Hyeon Kang, Kunrong Mei, Jianyu Zhang
(2023), pp. 1218-1222
Closed Access | Times Cited: 1
Computational approaches for identifying bioactive compounds inhibiting SARS-CoV-2 main protease
Piyatida Pojtanadithee
(2022)
Open Access
Page 1

Scroll to top